2007 Annual Meeting | Genetic Testing in Clinical Neurology

Date Friday 05/04/07

Time 09:00 AM - 12:45 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Katherine D. Mathews, MD, FAAN

Topic(s)

Learning Objectives Participants should understand when to order a genetic test, how to find an appropriate laboratory, how to interpret the results of common genetic tests, and potential pitfalls of genetic testing.

CME Available No CME available

Core Competencies Medical Knowledge, Practice-based Learning and Improvement

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
09:00 AM - 09:45 AM		Introduction to Genetic Testing Katherine D. Mathews, MD, FAAN
09:45 AM - 10:30 AM		Genetic Tests – What Are They and How Are They Done? Kevin M. Flanigan, MD, FAAN
10:30 AM - 10:45 AM		Break
10:45 AM - 11:45 AM		Cases from Clinical Practice, I Roberta A. Pagon, MD
11:45 AM - 12:30 PM		Cases from Clinical Practice, II Thomas D. Bird, MD, FAAN
12:30 PM - 12:45 PM		Questions and Answers

Faculty Disclosures
Thomas D. Bird, MD, FAAN	Dr. Bird has nothing to disclose.
Katherine D. Mathews, MD, FAAN	Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen.
Kevin M. Flanigan, MD, FAAN	Dr. Flanigan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apic Bio. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AavantiBio. Dr. Flanigan has stock in 4D Molecular Therapeutics. The institution of Dr. Flanigan has received research support from Abeona Therapeutics. The institution of Dr. Flanigan has received research support from Sarepta Therapeutics. The institution of Dr. Flanigan has received research support from Astellas Therapeutics. Dr. Flanigan has received intellectual property interests from a discovery or technology relating to health care.
Roberta A. Pagon, MD	No disclosure on file

��ɫ��

��ɫ��